| *Sponsored by Nutriband Inc.
Nasdaq Profile (NTRB) Is A Low Float Idea Backed By These 5 Potential Catalysts
April 30th Greetings, Friend!
Ain't that something?
My latest profile, a low float Nasdaq idea, came to life early Monday morning in impressive fashion.
Here's how things transpired:
#1. It closed at $3.50 in after hours on Friday.
#2. I brought it to your attention on Sunday evening.
#3. It surged to a high of $4.4299 on Monday.
That short term move resulted in a vertical chart blast of approximately 26% to get the week kicked off right!
Now, it's time to gather our focus once again for another breakout idea oozing with potential. First off, his is a low float idea with fewer than 6Mn shares in its float. This means volatility potential could be heightened.
Furthermore, in February, this Nasdaq idea saw an analyst reiterate their $13 target.
From its opening valuation Tuesday, that target suggests a potential upside of over 100%.
And just to fan the flames a bit more, this dynamo recently blazed through a jaw-dropping $7.50+ surge in just two days back in January-and since hitting its April lows, it’s already rocketed over 45% to this week’s highs!
That info and more is why Nutriband Inc. (Nasdaq: NTRB) is a pharmaceutical company climbing my watchlist this week.
Why? Part of its due to its innovative approach to transdermal drug delivery and its potential to revolutionize patient care, particularly in the field of pain management and abuse prevention.
The company's primary focus is on developing a portfolio of transdermal pharmaceutical products, with its flagship product being an abuse-deterrent fent-a-nyl patch incorporating their proprietary AVERSA™ technology.
This technology is designed to prevent abuse, misuse, diversion, and accidental exposure of drugs with high abuse potential, addressing a critical issue in the opioid crisis.
Learn More About The Company Here: NTRB Presentation. NTRB Website.
Nutriband's potential for growth and market impact is supported by several key potential catalysts:
#1. A Low Float Scenario: With roughly 5.11Mn shares in its float, volatility potential could be heightened at the drop of a hat.
#2. A $13 Analyst Target: Back in February, an analyst at Noble Capital Markets reiterated their $13 target for NTRB.
From Tuesday's opening valuation, this target projects NTRB to have a potential 100+% potential upside.
#3. A New Partnership Could Prove Fruitful: Nutriband signed an Associate Partnership with Charlotte FC to boost visibility for its AI Tape and promote its AVERSA abuse-deterrent patch platform, leveraging local manufacturing in North Carolina.
#4. Nutribran Helps Their Own Commercialization Efforts: The company received a USPTO trademark registration for "Nutriband™," supporting commercialization of its AVERSA platform, which targets abuse deterrence in transdermal drug delivery.
#5. A Groundbreaking Agreement Gets Formalized: Nutriband and Kindeva Drug Delivery formalized an exclusive development partnership for the Aversa™ Fent-a-nyl abuse-deterrent patch, involving shared development costs and milestone payments. -----
Coverage is officially reinitiated on Nutriband Inc. (Nasdaq: NTRB). When updates are available, I'll be in touch.
All the best, Dane James Editor Market Pulse Today
(Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.)
*MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors.
Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 04/29/2025 and ending on 04/30/2025 to publicly disseminate information about (NTRB:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid five thousand USD (“Funds”). To date, including under the previously described agreement, Thousand Sun Media LLC has been paid twenty thousand USD (“Funds”). These Funds were part of the funds that TD Media LLC received from Nutriband Inc., the issuer of (NTRB:US).
Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (NTRB:US).
Please see important disclosure information here: https://marketpulsetoday.com/disclosure/ntrb-ybhl5/#details | 
0 Response to "Nasdaq Profile (NTRB) Is A Low Float Idea Backed By These 5 Potential Catalysts"
Post a Comment